减重手术静脉血栓栓塞预防及方案对术后出血和血栓并发症影响的评估
该研究利用Cerner Health Facts数据库2003至2013年数据,纳入11860例腹腔镜袖状胃切除术和Roux-en-Y胃旁路术患者,分析VTE药物预防方案的使用情况及其对术后出血和血栓并发症的影响。结果显示术后预防较无预防降低DVT风险且出血风险低于术前预防,混合使用肝素和依诺肝素与更多输血相关。
要点
- 减重手术VTE药物预防使用不一致,33.62%患者未接受预防。
- 术后预防较无预防降低DVT风险(0.11% vs 0.58%,p<0.0001),且出血风险低于术前预防。
- 混合使用肝素和依诺肝素与输血需求增加相关(p<0.001)。
核心结论
- 减重手术VTE药物预防使用不一致,术后预防可降低VTE事件且出血风险低于术前预防。
- 混合使用肝素和依诺肝素与更多出血相关。
研究设计与样本
- 回顾性数据库研究,查询Cerner Health Facts数据库2003至2013年数据,使用ICD-9编码识别行腹腔镜袖状胃切除术和Roux-en-Y胃旁路术的患者,共纳入11860例。
主要发现
- 总体输血率、DVT率和PE率分别为2.48%、0.27%和0.18%。
- 无预防患者DVT发生率高于任何预防(0.58% vs 0.11%,p<0.0001),PE率无显著差异。
- 术前预防患者较术后预防患者更可能接受输血(OR 1.98,95% CI 1.28-3),VTE无显著差异。
- 术后预防组中混合方案与输血需求增加相关(p<0.001)。
关键数值与推荐
- 预防方案分为术前 alone(PreP)、术后 alone(PostP)、术前加术后(PPP)和无预防(NP)。
- PreP 634例(5.35%),PostP 4593例(38.73%),PPP 2646例(22.31%),NP 3987例(33.62%)。
临床怎么用
- 减重手术患者应考虑术后VTE药物预防以降低DVT风险,同时避免术前预防以减少出血。
- 避免混合使用肝素和依诺肝素,因其与更多输血相关。
局限性
- 研究为回顾性数据库分析,可能存在编码偏倚和未测量的混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Studies examining utilization and impact of venous thromboembolism (VTE) chemoprophylaxis for patients undergoing bariatric surgery are limited. Determination of the optimal prophylactic regimen to minimize complications is crucial. METHODS: The Cerner Health Facts database from 2003 to 2013 was queried using ICD-9 codes to identify patients undergoing laparoscopic sleeve gastrectomy (LSG) and Roux-en-Y gastric bypass (RYGB). VTE chemoprophylaxis regimens were divided into pre-operative alone (PreP), post-operative alone (PostP), both pre-operative and post-operative (PPP), or no prophylaxis (NP). Specific chemoprophylaxis agents were compared. Comparisons in inpatient clinical outcomes were based on univariate analysis and multivariable logistic regression when appropriate. RESULTS: We identified 11,860 patients who underwent LSG and RYGB. 634 (5.35%) had PreP, 4593 (38.73%) had PostP, 2646 (22.31%) had PPP, and 3987 (33.62%) had NP. The overall rates of transfusion, DVT, and PE were 2.48, 0.27, and 0.18%, respectively. Patients without chemoprophylaxis had higher rate of DVT compared to any chemoprophylaxis (0.58 vs 0.11%, p < 0.0001), without any significant difference in PE rate. Patients with pre-operative chemoprophylaxis were more likely to receive transfusion compared to patients with post-operative prophylaxis alone (OR 1.98, 95% CI 1.28-3), without significant difference in having VTE. When examining heparin versus enoxaparin versus mixed regimen in the PostP group, mixed regimen was associated with increased transfusion requirements (p < 0.001). CONCLUSIONS: Bariatric surgical VTE chemoprophylaxis utilization is inconsistent. In this study, post-operative VTE chemoprophylaxis was associated with decreased VTE events compared to NP, while minimizing bleeding compared to PreP. Mixed therapy using heparin and enoxaparin was associated with more bleeding.
引用
- Altieri MS, Yang J, Hajagos J, et al. Evaluation of VTE prophylaxis and the impact of alternate regimens on post-operative bleeding and thrombotic complications following bariatric procedures. Surg Endosc. 2018. PMID: 29766305. doi:10.1007/s00464-018-6231-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。